Nyx Technologies Ltd

General Data

supplementary funding
Reg Number
515510758
Sector
Digital Health
Established
2016
No. of Employees
10
Stage
R&D
Additional Funding
1

Description

nn

Technology

NYX's innovative neurotechnology platform called Cognyx helps improving sleep quality during the night and reduces stress during the day. The Neural Activation System (NAS) is a brand new proprietary system that adapts to brain function based on information analyzed in the sensing stage. The NYX headband uses AI and the Neural Activation System. This combination allows NYX to replicate natural brain waves and patterns so it can read brain signals and send back personalized signals to safely induce sleep, all in real time.

Targeted Customers

Individuals, Psychologists, Organizations.

Management personnel

Eyal Lewin - CEO
Ophir Orenstein - CTO & Co-Founder

Contact information

Name
EYAL LEWIN
Phone
0544589493
Website
http://www.nyx-tech.com
Country
Israel
Zip
3303140

Tags

Consumer ElectronicsDigital HealthHealthcare ITHealthtechInsomnia TreatmentLife SciencesManaged CareMedTechMental HealthNeurofeedbackSDKWearablesWellbeing

Classified Technologies

Medical Engineering

Winning details

Route name
Winning year

The Expedited Program
The Expedited Program
2024
R&D Program second/third year request for Entitled Growth Corporate
R&D Program second/third year request for Entitled Growth Corporate
2023